Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 August 2020 | Story Thabo Kessah | Photo Supplied
Lebohang Masoabi believes she is a champion woman as she commits her time to nurture other champions.

Growing up with an inferiority complex has taught Lebohang Masoabi to flourish in her adult life. She credits former Vice-Chairperson of the University of the Free State’s Council, Dr Nthabeleng Rammile, as a woman who continues to inspire her. She recently won an Innovation in Learning and Teaching award during the Qwaqwa Campus Centre for Teaching and Learning’s Excellence in Learning and Teaching Awards. 

She has just completed her MCom degree in Business Management, focusing on the role of entrepreneurial education on attitudes and intentions of university students. 

Please tell us about yourself: Who you are and what you do? 

My name is Lebohang Masoabi. I am a Lecturer in the Department of Business Management at the University of the Free State Qwaqwa Campus. My areas of expertise include, but are not limited to, entrepreneurship and marketing.

Is there a woman who inspires you and who you would like to celebrate this Women’s Month, and why?

Dr Nthabeleng Rammile. She is intentional and unapologetic about pursuing her destiny. She is a great example of defying limitations. She constantly challenges her abilities. She oozes confidence. But above all, I love how she is passionate about the growth and development of other women, and how she has made it her life’s work to ensure that other women succeed in pursuit of their dreams. 

What are some of the challenges you’ve faced in your life that have made you a better woman?

Self-esteem issues: I had to learn to love myself and believe in myself and when I overcame that, I was unstoppable.

Inferiority complex: I was always afraid to express my full potential, wondering if I am worth it compared to others in my professional and personal space. I then realised that I am not weak, I am not vulnerable, I am not a damsel in distress. The day I realised my full potential as a woman, I flourished.

 

I had to learn to love myself and believe in myself and when I overcame that, I was unstoppable.

What advice would you give to the 15-year-old you?

• You are worth more than you think.
• Not everyone is going to like you, and that is fine.
• Be brave and do what scares you.
• Be kind to yourself.
• Forgive quickly, move on quickly.
• The girls who did not like you then, want to be you now!
• Learn to breathe through the tough moments, it’s not the end of the world.

What would you say makes you a champion woman [of the UFS]?

For the past four years on our campus, I have committed my time and energy to mentor students who are in quest of their professional and personal development, some of whom have launched their careers and have become champions in their own spaces.

So, my answer to this question is that what makes me a champion woman of the UFS is the fact that I nurture other champions!

 


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept